GRAVISTAT

Main information

  • Trade name:
  • GRAVISTAT Coated tablet 0,05MG/0,125MG
  • Dosage:
  • 0,05MG/0,125MG
  • Pharmaceutical form:
  • Coated tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 3X21 Blister
  • Prescription type:
  • on prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • GRAVISTAT Coated tablet 0,05MG/0,125MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Levonorgestrel and ethinyl estradiol
  • Product summary:
  • GRAVISTAT 125

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 17/ 658/92-C
  • Authorization date:
  • 23-05-2014
  • EAN code:
  • 8590322001356
  • Last update:
  • 28-02-2017

There are no safety alerts related to this product.